Anna Hermansson-Bornefalk - Publications

Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease.

Journal: ERJ open research

Published: July 09, 2021

Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study.

Journal: The European respiratory journal

Published: July 17, 2020

Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease.

Journal: Journal of pain and symptom management

Published: May 12, 2020

Respiratory outcomes after a 1-year treatment of obstructive sleep apnoea with bibloc versus monobloc oral appliances: a multicentre, randomized equivalence trial.

Journal: Acta odontologica Scandinavica

Published: March 04, 2020

Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.

Journal: BMJ open respiratory research

Published: February 07, 2019

Surgery for Chronic Otitis Media Causes Greater Taste Disturbance Than Surgery for Otosclerosis.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: December 13, 2018

Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease.

Journal: BMJ open respiratory research

Published: November 12, 2018

REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol.

Journal: BMC pulmonary medicine

Published: May 28, 2018

Use of bibloc and monobloc oral appliances in obstructive sleep apnoea: a multicentre, randomized, blinded, parallel-group equivalence trial.

Journal: European journal of orthodontics

Published: May 18, 2018

Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.

Journal: The Cochrane database of systematic reviews

Published: November 26, 2016

Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease.

Journal: PloS one

Published: July 01, 2016

Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis: A population-based longitudinal study.

Journal: Respirology (Carlton, Vic.)

Published: August 04, 2015